FDA Approves Second Gene Therapy for Hemophilia B ...Middle East

Pfizer reported a list price of $3.5 million for its new gene therapy, Beqvez, for adults with this rare bleeding disorder. Medscape Medical News

Hence then, the article about fda approves second gene therapy for hemophilia b was published today ( Friday 26/04/2024 - 05:09 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Second Gene Therapy for Hemophilia B )

Also on site :

• Gwyneth Paltrow’s surprisingly racy Oscars 2026 dress is slit all the way up the sides
• TIER IV unveils AI-based Level 4 autonomous driving, accelerating global platform expansion across Japan, U.S. and Europe
• Conan O’Brien Starts Oscars by Roasting Timothée Chalamet’s Ballet and Opera Controversy as Camera Cuts to ‘Marty Supreme’ Star Laughing